179 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
101 | 20022592 | A novel role for glyceraldehyde-3-phosphate dehydrogenase and monoamine oxidase B cascade in ethanol-induced cellular damage. | 2010 May 1 | 2 |
102 | 20195940 | [On the role of MAO B inhibitors and NMDA antagonists in the therapy of Parkinson's disease]. | 2010 Mar | 1 |
103 | 20197647 | Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonism. | 2010 | 1 |
104 | 20236308 | Efficacy and tolerability of rasagiline in daily clinical use--a post-marketing observational study in patients with Parkinson's disease. | 2010 Sep | 1 |
105 | 20445015 | Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline. | 2010 Dec | 4 |
106 | 20517484 | The role of rasagiline in the treatment of Parkinson's disease. | 2010 May 25 | 3 |
107 | 20600573 | Rasagiline: a novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity. | 2010 Nov | 4 |
108 | 20624440 | Rasagiline protects against alpha-synuclein induced sensitivity to oxidative stress in dopaminergic cells. | 2010 Nov | 1 |
109 | 20977789 | [Rasagiline is not for all Parkinson disease patients: the ADAGIO study]. | 2010 | 1 |
110 | 20979033 | [Rasagiline: effectiveness and protection in Parkinson's disease]. | 2010 Nov 1 | 1 |
111 | 21389939 | [Efficacy of rasagiline in patients with advanced Parkinson's disease with motor fluctuation (azimut study)]. | 2010 | 2 |
112 | 23908775 | Pharmacology of Rasagiline, a New MAO-B Inhibitor Drug for the Treatment of Parkinson's Disease with Neuroprotective Potential. | 2010 Jul | 3 |
113 | 19110207 | Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugs. | 2009 Jan | 1 |
114 | 19384601 | Comparative neuroprotective effects of rasagiline and aminoindan with selegiline on dexamethasone-induced brain cell apoptosis. | 2009 Apr | 1 |
115 | 19526291 | Glyceraldehyde-3-phosphate dehydrogenase-monoamine oxidase B-mediated cell death-induced by ethanol is prevented by rasagiline and 1-R-aminoindan. | 2009 Aug | 5 |
116 | 19673610 | Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease. | 2009 Aug | 1 |
117 | 19733607 | Lack of clinically significant interactions between concomitantly administered rasagiline and escitalopram. | 2009 Nov 13 | 1 |
118 | 19753135 | Role of rasagiline in treating Parkinson's disease: Effect on disease progression. | 2009 Aug | 2 |
119 | 18067186 | Rasagiline improves freezing in a patient with primary progressive freezing gait. | 2008 Feb 15 | 1 |
120 | 18072817 | Spotlight on rasagiline in Parkinson's disease. | 2008 | 4 |
121 | 18307054 | [Rasagiline in Parkinson's disease]. | 2008 May | 1 |
122 | 18668620 | Medical treatment of freezing of gait. | 2008 | 1 |
123 | 18678789 | Transtelephonic home blood pressure to assess the monoamine oxidase-B inhibitor rasagiline in Parkinson disease. | 2008 Sep | 1 |
124 | 18833504 | [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment]. | 2008 Oct | 2 |
125 | 18937611 | The increasing role of monoamine oxidase type B inhibitors in Parkinson's disease therapy. | 2008 Nov | 2 |
126 | 18952510 | Rapid and sensitive liquid chromatography-tandem mass spectrometry: assay development, validation and application to a human pharmacokinetic study. | 2008 Nov 15 | 1 |
127 | 19004128 | [The use of a new MAO B inhibitor rasagiline in the treatment of motor fluctuations in Parkinson's disease]. | 2008 | 1 |
128 | 17055733 | Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism. | 2007 Jan | 2 |
129 | 17347320 | The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by two series of novel carbamates. | 2007 Jun | 1 |
130 | 17495756 | Advances in the pharmacologic management of early Parkinson disease. | 2007 May | 2 |
131 | 17545750 | Monamine oxidase inhibitors: current and emerging agents for Parkinson disease. | 2007 May-Jun | 2 |
132 | 17630819 | Medical management of levodopa-associated motor complications in patients with Parkinson's disease. | 2007 | 1 |
133 | 17635668 | Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro. | 2007 Oct | 2 |
134 | 17683172 | Rasagiline: a review of its use in the management of Parkinson's disease. | 2007 | 4 |
135 | 17702535 | Community and long-term care management of Parkinson's disease in the elderly: focus on monoamine oxidase type B inhibitors. | 2007 | 1 |
136 | 18035186 | Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease. | 2007 Sep | 2 |
137 | 18041937 | Monoamine oxidase-B inhibition in the treatment of Parkinson's disease. | 2007 Dec | 1 |
138 | 18267281 | New strategies in motor parkinsonism. | 2007 | 1 |
139 | 18488080 | Rasagiline - a novel MAO B inhibitor in Parkinson's disease therapy. | 2007 Jun | 3 |
140 | 16425668 | Drugs in development for Parkinson's disease: an update. | 2006 Jan | 1 |
141 | 16450340 | Rasagiline improves quality of life in patients with early Parkinson's disease. | 2006 May | 1 |
142 | 16451296 | Rasagiline: defining the role of a novel therapy in the treatment of Parkinson's disease. | 2006 Feb | 1 |
143 | 16675649 | Rasagiline: A second-generation monoamine oxidase type-B inhibitor for the treatment of Parkinson's disease. | 2006 May 15 | 5 |
144 | 16717254 | Rationale for considering that propargylamines might be neuroprotective in Parkinson's disease. | 2006 May 23 | 1 |
145 | 16717255 | Clinical trials with rasagiline: evidence for short-term and long-term effects. | 2006 May 23 | 1 |
146 | 16828804 | Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms. | 2006 Oct 25 | 1 |
147 | 16856145 | Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline. | 2006 Oct | 2 |
148 | 16935943 | A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processing. | 2006 Oct | 1 |
149 | 17017568 | Involvement of multiple survival signal transduction pathways in the neuroprotective, neurorescue and APP processing activity of rasagiline and its propargyl moiety. | 2006 | 1 |
150 | 17296539 | Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease. | 2006 Dec | 1 |